研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2017 年 · SMMR
Statistical Methods in Medical Research,2017 年发表的 178 篇,新的在前。点标题看作者和摘要。回到 2017 年
- Estimation of the relative difference (or relative risk reduction) under the sequential parallel comparison design · SMMR · 2017-12-28 · 在第 1 页
- Bayesian Phase II optimization for time-to-event data based on historical information · SMMR · 2017-12-28 · 在第 1 页
- A test of inflated zeros for Poisson regression models · SMMR · 2017-12-28 · 在第 1 页
- Methods for assessing and controlling placebo effects · SMMR · 2017-12-26 · 在第 1 页
- Bayesian hidden Markov models for delineating the pathology of Alzheimer’s disease · SMMR · 2017-12-26 · 在第 1 页
- A stratification approach using logit-based models for confounder adjustment in the study of continuous outcomes · SMMR · 2017-12-26 · 在第 1 页
- A Bayesian framework for performance assessment and comparison of imaging biomarker quantification methods · SMMR · 2017-12-22 · 在第 1 页
- A two-stage approach for estimating the parameters of an age-group epidemic model from incidence data · SMMR · 2017-12-20 · 在第 1 页
- Permutations of functional magnetic resonance imaging classification may not be normally distributed · SMMR · 2017-12-18 · 在第 1 页
- Optimized adaptive enrichment designs · SMMR · 2017-12-18 · 在第 1 页
- Estimating scaled treatment effects with multiple outcomes · SMMR · 2017-12-18 · 在第 1 页
- Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees · SMMR · 2017-12-18 · 在第 1 页
- Parametric estimates for the receiver operating characteristic curve generalization for non-monotone relationships · SMMR · 2017-12-15 · 在第 1 页
- Identifying the source of food-borne disease outbreaks: An application of Bayesian variable selection · SMMR · 2017-12-15 · 在第 1 页
- Causal inference with measurement error in outcomes: Bias analysis and estimation methods · SMMR · 2017-12-15 · 在第 1 页
- Bayesian nonparametric inference for the three-class Youden index and its associated optimal cutoff points · SMMR · 2017-12-15 · 在第 1 页
- Test procedure and sample size determination for a proportion study using a double-sampling scheme with two fallible classifiers · SMMR · 2017-12-12 · 在第 2 页
- Determining the likely place of HIV acquisition for migrants in Europe combining subject-specific information and biomarkers data · SMMR · 2017-12-12 · 在第 2 页
- Confidence intervals for differences between volumes under receiver operating characteristic surfaces (VUS) and generalized Youden indices (GYIs) · SMMR · 2017-12-12 · 在第 2 页
- Bootstrap-based procedures for inference in nonparametric receiver-operating characteristic curve regression analysis · SMMR · 2017-12-12 · 在第 2 页
- An oncology clinical trial design with randomization adaptive to both short- and long-term responses · SMMR · 2017-12-12 · 在第 2 页
- A model for meta-analysis of correlated binary outcomes: The case of split-body interventions · SMMR · 2017-12-12 · 在第 2 页
- Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data · SMMR · 2017-12-11 · 在第 2 页
- Bayesian proportional hazards model with latent variables · SMMR · 2017-12-11 · 在第 2 页
- Sharpening randomization-based causal inference for 2 2 factorial designs with binary outcomes · SMMR · 2017-12-05 · 在第 2 页
- Smooth time-dependent receiver operating characteristic curve estimators · SMMR · 2017-11-29 · 在第 3 页
- Bridging observational studies and randomized experiments by embedding the former in the latter · SMMR · 2017-11-29 · 在第 3 页
- Sample size requirements for learning to classify with high-dimensional biomarker panels · SMMR · 2017-11-28 · 在第 3 页
- Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case—Application to the early diagnosis of Alzheimer disease · SMMR · 2017-11-28 · 在第 3 页
- Robust inference under the beta regression model with application to health care studies · SMMR · 2017-11-27 · 在第 3 页
- Futility for subgroup analyses in the adaptive signature design · SMMR · 2017-11-27 · 在第 3 页
- Efficient baseline utilization for incomplete block crossover clinical trials · SMMR · 2017-11-27 · 在第 3 页
- Measurement error correction in the least absolute shrinkage and selection operator model when validation data are available · SMMR · 2017-11-23 · 在第 3 页
- Bayesian latent time joint mixed effect models for multicohort longitudinal data · SMMR · 2017-11-23 · 在第 3 页
- Are latent variable models preferable to composite score approaches when assessing risk factors of change? Evaluation of type-I error and statistical power in longitudinal cognitive studies · SMMR · 2017-11-22 · 在第 3 页
- The compositional isotemporal substitution model: A method for estimating changes in a health outcome for reallocation of time between sleep, physical activity and sedentary behaviour · SMMR · 2017-11-20 · 在第 3 页
- Efficient estimation of disease odds ratios for follow-up genetic association studies · SMMR · 2017-11-20 · 在第 4 页
- Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods · SMMR · 2017-11-20 · 在第 4 页
- Robustness of crossover trials against subject drop-out – Examples of perpetually connected designs · SMMR · 2017-11-16 · 在第 4 页
- Power and sample size for multivariate logistic modeling of unmatched case-control studies · SMMR · 2017-11-16 · 在第 4 页
- Exact statistical calculation of the uncertainty term in the decision limits of the GH-2000 score for growth hormone misuse (doping) detection · SMMR · 2017-11-16 · 在第 4 页
- Addressing geographic confounding through spatial propensity scores: a study of racial disparities in diabetes · SMMR · 2017-11-16 · 在第 4 页
- A probability based method for selecting the optimal personalized treatment from multiple treatments · SMMR · 2017-11-16 · 在第 4 页
- Model-based sensitivity analysis for outcome reporting bias in the meta analysis of benefit and harm outcomes · SMMR · 2017-11-14 · 在第 4 页
- Variable selection for accelerated lifetime models with synthesized estimation techniques · SMMR · 2017-11-09 · 在第 4 页
- Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect · SMMR · 2017-11-09 · 在第 4 页
- Estimating individual benefits of medical or behavioral treatments in severely ill patients · SMMR · 2017-11-08 · 在第 4 页
- Adjustment for treatment changes in epilepsy trials: A comparison of causal methods for time-to-event outcomes · SMMR · 2017-11-08 · 在第 4 页
- A stochastic estimation procedure for intermittently-observed semi-Markov multistate models with back transitions · SMMR · 2017-11-08 · 在第 4 页
- A joint model for multivariate hierarchical semicontinuous data with replications · SMMR · 2017-11-08 · 在第 4 页
- Modelling breast cancer tumour growth for a stable disease population · SMMR · 2017-11-06 · 在第 4 页
- Bayesian imputation of time-varying covariates in linear mixed models · SMMR · 2017-10-25 · 在第 5 页
- Multiply adjusted comparisons: A meta-analysis method to compare single-arm clinical-trial data to literature results regarding a competitor · SMMR · 2017-10-13 · 在第 6 页
- Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials · SMMR · 2017-10-13 · 在第 6 页
- Marginal structural models to estimate the effects of time-varying treatments on clustered outcomes in the presence of interference · SMMR · 2017-10-05 · 在第 6 页
- A hierarchical modeling approach for assessing the safety of exposure to complex antiretroviral drug regimens during pregnancy · SMMR · 2017-10-03 · 在第 6 页
- Sample size considerations for paired experimental design with incomplete observations of continuous outcomes · SMMR · 2017-09-28 · 在第 7 页
- Joint modeling of longitudinal and survival data with a covariate subject to a limit of detection · SMMR · 2017-09-28 · 在第 7 页
- Scalable collaborative targeted learning for high-dimensional data · SMMR · 2017-09-22 · 在第 7 页
- Bayesian quantile regression-based partially linear mixed-effects joint models for longitudinal data with multiple features · SMMR · 2017-09-22 · 在第 8 页
- Population metrics for suicide events: A causal inference approach · SMMR · 2017-09-21 · 在第 8 页
- Regression standardization and attributable fraction estimation with between-within frailty models for clustered survival data · SMMR · 2017-09-13 · 在第 8 页
- Sample size considerations for n -of-1 trials · SMMR · 2017-09-07 · 在第 8 页
- Competing risks modeling of cumulative effects of time-varying drug exposures · SMMR · 2017-09-07 · 在第 8 页
- Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis · SMMR · 2017-09-07 · 在第 8 页
- Bayesian treatment comparison using parametric mixture priors computed from elicited histograms · SMMR · 2017-09-05 · 在第 8 页
- Flexible Bayesian P-splines for smoothing age-specific spatio-temporal mortality patterns · SMMR · 2017-08-28 · 在第 9 页
- Survival forests for data with dependent censoring · SMMR · 2017-08-24 · 在第 9 页
- Adjustment for time-dependent unmeasured confounders in marginal structural Cox models using validation sample data · SMMR · 2017-08-24 · 在第 9 页
- Improved conditional imputation for linear regression with a randomly censored predictor · SMMR · 2017-08-22 · 在第 9 页
- A method to compare the performance of two molecular diagnostic tools in the absence of a gold standard · SMMR · 2017-08-17 · 在第 9 页
- Evaluating disease prediction models using a cohort whose covariate distribution differs from that of the target population · SMMR · 2017-08-16 · 在第 9 页
- Improved matrix pooling · SMMR · 2017-08-10 · 在第 9 页
- Interpretation of mixed models and marginal models with cohort attrition due to death and drop-out · SMMR · 2017-08-08 · 在第 10 页
- Meta-analysis of rare binary events in treatment groups with unequal variability · SMMR · 2017-07-31 · 在第 11 页
- Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer’s disease · SMMR · 2017-07-28 · 在第 11 页
- Simulation-based sensitivity analysis for non-ignorably missing data · SMMR · 2017-07-26 · 在第 11 页
- Joint incorporation of randomised and observational evidence in estimating treatment effects · SMMR · 2017-07-26 · 在第 11 页
- Hierarchical Bayes approach for subgroup analysis · SMMR · 2017-07-26 · 在第 11 页
- Efficient body fat estimation using multistage pair ranked set sampling · SMMR · 2017-07-18 · 在第 11 页
- A model averaging approach for estimating propensity scores by optimizing balance · SMMR · 2017-07-17 · 在第 11 页
- Two-way partial AUC and its properties · SMMR · 2017-07-14 · 在第 11 页
- Prediction and tolerance intervals for dynamic treatment regimes · SMMR · 2017-07-11 · 在第 12 页
- Meta-analysis without study-specific variance information: Heterogeneity case · SMMR · 2017-07-06 · 在第 12 页
- A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses · SMMR · 2017-07-06 · 在第 12 页
- Empirical likelihood inference in randomized clinical trials · SMMR · 2017-07-05 · 在第 12 页
- A robust imputation method for missing responses and covariates in sample selection models · SMMR · 2017-07-05 · 在第 12 页
- The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation · SMMR · 2017-07-04 · 在第 12 页
- Testing for qualitative heterogeneity: An application to composite endpoints in survival analysis · SMMR · 2017-07-03 · 在第 12 页
- Regularized approach for data missing not at random · SMMR · 2017-07-03 · 在第 12 页
- Nonparametric combination tests for comparing two survival curves with informative and non-informative censoring · SMMR · 2017-06-28 · 在第 13 页
- Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes · SMMR · 2017-06-28 · 在第 13 页
- Causality on longitudinal data: Stable specification search in constrained structural equation modeling · SMMR · 2017-06-28 · 在第 13 页
- Bayesian cure rate models induced by frailty in survival analysis · SMMR · 2017-06-28 · 在第 13 页
- A joint overdispersed marginalized random-effects model for analyzing two or more longitudinal ordinal responses · SMMR · 2017-06-28 · 在第 13 页
- Modelling and sample size reestimation for longitudinal count data with incomplete follow up · SMMR · 2017-06-21 · 在第 13 页
- Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors · SMMR · 2017-06-20 · 在第 13 页
- Functional principal component analysis of glomerular filtration rate curves after kidney transplant · SMMR · 2017-06-20 · 在第 13 页
- Exact Bayesian p-values for a test of independence in a 2 × 2 contingency table with missing data · SMMR · 2017-06-20 · 在第 13 页
- Controlling response dependence in the measurement of change using the Rasch model · SMMR · 2017-06-20 · 在第 13 页
- A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution · SMMR · 2017-06-20 · 在第 13 页
- A comparative study of subgroup identification methods for differential treatment effect: Performance metrics and recommendations · SMMR · 2017-06-20 · 在第 13 页
- Landmark cure rate models with time-dependent covariates · SMMR · 2017-06-19 · 在第 13 页
- Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations · SMMR · 2017-06-19 · 在第 13 页
- Bayesian analysis of longitudinal dyadic data with informative missing data using a dyadic shared-parameter model · SMMR · 2017-06-19 · 在第 13 页
- Modelling disease activity in juvenile dermatomyositis: A Bayesian approach · SMMR · 2017-06-07 · 在第 14 页
- A unified approach for assessing heterogeneity in age–period–cohort model parameters using random effects · SMMR · 2017-06-07 · 在第 14 页
- A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment · SMMR · 2017-06-07 · 在第 14 页
- Propensity score analysis with partially observed covariates: How should multiple imputation be used? · SMMR · 2017-06-02 · 在第 14 页
- Bayesian two-part bent-cable Tobit models with skew distributions: Application to AIDS studies · SMMR · 2017-05-31 · 在第 15 页
- Compositional data analysis for physical activity, sedentary time and sleep research · SMMR · 2017-05-30 · 在第 15 页
- Testing for differentially expressed genetic pathways with single-subject N-of-1 data in the presence of inter-gene correlation · SMMR · 2017-05-29 · 在第 15 页
- Dissimilarity for functional data clustering based on smoothing parameter commutation · SMMR · 2017-05-24 · 在第 15 页
- Two-part models with stochastic processes for modelling longitudinal semicontinuous data: Computationally efficient inference and modelling the overall marginal mean · SMMR · 2017-05-23 · 在第 15 页
- Extended two-stage adaptive designs with three target responses for phase II clinical trials · SMMR · 2017-05-23 · 在第 15 页
- Proportional hazards under Conway–Maxwell-Poisson cure rate model and associated inference · SMMR · 2017-05-19 · 在第 15 页
- Prediction accuracy for the cure probabilities in mixture cure models · SMMR · 2017-05-19 · 在第 15 页
- Bayesian meta-analysis: The role of the between-sample heterogeneity · SMMR · 2017-05-16 · 在第 15 页
- Expected p -values in light of an ROC curve analysis applied to optimal multiple testing procedures · SMMR · 2017-05-15 · 在第 15 页
- Modeling qRT-PCR dynamics with application to cancer biomarker quantification · SMMR · 2017-05-14 · 在第 15 页
- Model validation and selection for personalized medicine using dynamic-weighted ordinary least squares · SMMR · 2017-05-10 · 在第 16 页
- Change-point detection for infinite horizon dynamic treatment regimes · SMMR · 2017-05-10 · 在第 16 页
- A gap time model based on a multiplicative marginal rate function that accounts for zero-recurrence units · SMMR · 2017-05-10 · 在第 16 页
- Promoting structural effects of covariates in the cure rate model with penalization · SMMR · 2017-05-08 · 在第 16 页
- Modeling agreement on bounded scales · SMMR · 2017-05-08 · 在第 16 页
- Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C -statistic and calibration measures? · SMMR · 2017-05-08 · 在第 16 页
- Hierarchical models for sharing information across populations in phase I dose-escalation studies · SMMR · 2017-05-08 · 在第 16 页
- Evaluating the impact of treating the optimal subgroup · SMMR · 2017-05-08 · 在第 16 页
- Dynamic treatment regimes, past, present, and future: A conversation with experts · SMMR · 2017-05-08 · 在第 16 页
- Comparing heteroscedastic measurement systems with the probability of agreement · SMMR · 2017-05-08 · 在第 16 页
- Multilevel growth curve models that incorporate a random coefficient model for the level 1 variance function · SMMR · 2017-05-01 · 在第 17 页
- A change-point model for detecting heterogeneity in ordered survival responses · SMMR · 2017-05-01 · 在第 17 页
- Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques · SMMR · 2017-04-20 · 在第 18 页
- A Bayesian hierarchical model for discrete choice data in health care · SMMR · 2017-04-18 · 在第 18 页
- Mixed-effects location and scale Tobit joint models for heterogeneous longitudinal data with skewness, detection limits, and measurement errors · SMMR · 2017-04-17 · 在第 18 页
- Constraint approaches to the estimation of relative risk · SMMR · 2017-04-13 · 在第 18 页
- A composite likelihood approach to predict the sex of the baby · SMMR · 2017-04-10 · 在第 19 页
- Guidelines on constructing funnel plots for quality indicators: A case study on mortality in intensive care unit patients · SMMR · 2017-03-23 · 在第 20 页
- Optimal quantile level selection for disease classification and biomarker discovery with application to electrocardiogram data · SMMR · 2017-03-17 · 在第 20 页
- Linking temporal medical records using non-protected health information data · SMMR · 2017-03-16 · 在第 20 页
- Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies · SMMR · 2017-03-14 · 在第 21 页
- A blended link approach to relative risk regression · SMMR · 2017-03-13 · 在第 21 页
- Robust functional regression model for marginal mean and subject-specific inferences · SMMR · 2017-03-03 · 在第 21 页
- A robust likelihood approach to inference about the difference between two multinomial distributions in paired designs · SMMR · 2017-03-03 · 在第 21 页
- A Bayesian approach to the g-formula · SMMR · 2017-03-02 · 在第 21 页
- Leveraging electronic health records for predictive modeling of post-surgical complications · SMMR · 2017-03-01 · 在第 21 页
- Adaptive Designs for Non-inferiority Trials with Multiple Experimental Treatments · SMMR · 2017-03-01 · 在第 21 页
- Quantitative imaging biomarkers: Effect of sample size and bias on confidence interval coverage · SMMR · 2017-02-27 · 在第 21 页
- A doubly robust approach for cost–effectiveness estimation from observational data · SMMR · 2017-02-27 · 在第 21 页
- Predicting the cure rate of breast cancer using a new regression model with four regression structures · SMMR · 2017-02-23 · 在第 22 页
- Conditional independence test by generalized Kendall’s tau with generalized odds ratio · SMMR · 2017-02-23 · 在第 22 页
- Bias away from the null due to miscounted outcomes? A case study on the TORCH trial · SMMR · 2017-02-23 · 在第 22 页
- An ad hoc method for dual adjusting for measurement errors and nonresponse bias for estimating prevalence in survey data: Application to Iranian mental health survey on any illicit drug use · SMMR · 2017-02-23 · 在第 22 页
- Individual treatment effect prediction for amyotrophic lateral sclerosis patients · SMMR · 2017-02-21 · 在第 22 页
- Including historical data in the analysis of clinical trials: Is it worth the effort? · SMMR · 2017-02-21 · 在第 22 页
- Comparison of beta-binomial regression model approaches to analyze health-related quality of life data · SMMR · 2017-02-13 · 在第 22 页
- Nonparametric estimation and inference for polytomous discrimination index · SMMR · 2017-02-09 · 在第 23 页
- Designing fecal microbiota transplant trials that account for differences in donor stool efficacy · SMMR · 2017-02-09 · 在第 23 页
- Model selection in multivariate semiparametric regression · SMMR · 2017-02-06 · 在第 23 页
- Deriving percentage study weights in multi-parameter meta-analysis models: with application to meta-regression, network meta-analysis and one-stage individual participant data models · SMMR · 2017-02-06 · 在第 23 页
- Biomarker validation with an imperfect reference: Issues and bounds · SMMR · 2017-02-06 · 在第 23 页
- Flexible modeling of the hazard rate and treatment effects in long-term survival studies · SMMR · 2017-02-02 · 在第 23 页
- Estimating marginal and incremental effects in the analysis of medical expenditure panel data using marginalized two-part random-effects generalized Gamma models: Evidence from China healthcare cost data · SMMR · 2017-01-31 · 在第 23 页
- Estimation of indirect effect when the mediator is a censored variable · SMMR · 2017-01-30 · 在第 23 页
- Bayesian joint analysis of heterogeneous- and skewed-longitudinal data and a binary outcome, with application to AIDS clinical studies · SMMR · 2017-01-30 · 在第 23 页
- Statistical methods for unidirectional switch designs: Past, present, and future · SMMR · 2017-01-26 · 在第 24 页
- Conditional overdispersed models: Application to count area data · SMMR · 2017-01-26 · 在第 24 页
- Performance of methods for estimating the effect of covariates on group membership probabilities in group-based trajectory models · SMMR · 2017-01-18 · 在第 24 页
- The LMSR method for providing a multidimensional understanding of growth standard in human fetuses · SMMR · 2017-01-17 · 在第 24 页
- CUSUM chart to monitor autocorrelated counts using Negative Binomial GARMA model · SMMR · 2017-01-17 · 在第 24 页
- An efficient test based on the inferential model for the non-inferiority of odds ratio in matched-pairs design · SMMR · 2017-01-17 · 在第 25 页
- Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model · SMMR · 2017-01-16 · 在第 25 页
- Mediation analysis for count and zero-inflated count data · SMMR · 2017-01-08 · 在第 25 页
- Jointly determining significance levels of primary and replication studies by controlling the false discovery rate in two-stage genome-wide association studies · SMMR · 2017-01-08 · 在第 25 页
- Construction of longitudinal prediction targets using semisupervised learning · SMMR · 2017-01-08 · 在第 25 页
- Clinical dose–response for a broad set of biological products: A model-based meta-analysis · SMMR · 2017-01-08 · 在第 25 页
- A novel rank-based non-parametric method for longitudinal ordinal data · SMMR · 2017-01-08 · 在第 25 页
- The analysis of multivariate longitudinal data: A review · SMMR · 2017-01-05 · 在第 25 页